Nexalin Technology Company Leadership
| NXL Stock | USD 0.75 0.01 1.32% |
Nexalin Technology employs about 6 people. The company is managed by 8 executives with a total tenure of roughly 14 years, averaging almost 1.0 years of service per executive, having 0.75 employees per reported executive. Inspection of Nexalin Technology's management performance can provide insight into the company performance.
Nexalin Technology Management Team Effectiveness
The company has Return on Asset of (1.0658) % which means that on every $100 spent on assets, it lost $1.0658. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.7846) %, meaning that it generated no profit with money invested by stockholders. Nexalin Technology's management efficiency ratios could be used to measure how well Nexalin Technology manages its routine affairs as well as how well it operates its assets and liabilities.Nexalin Technology maintains a total of 18.65 Million outstanding shares. Nexalin Technology secures 13.78 % of its outstanding shares held by insiders and 3.78 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Nexalin Technology in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Nexalin Technology, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Nexalin Technology Workforce Comparison
Nexalin Technology is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 882. Nexalin Technology maintains roughly 6.0 in number of employees contributing less than 1% to equities under Health Care industry.
Nexalin Technology Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nexalin Technology insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nexalin Technology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Nexalin Technology insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Van Fleet Justin a day ago Insider Trading | ||
Van Fleet Justin 2 days ago Insider Trading | ||
Van Fleet Justin 3 days ago Insider Trading | ||
Van Fleet Justin few days ago Insider Trading | ||
Van Fleet Justin few days ago Insider Trading | ||
Van Fleet Justin six days ago Insider Trading | ||
Van Fleet Justin over a week ago Insider Trading | ||
Van Fleet Justin over a week ago Insider Trading |
Nexalin Technology Notable Stakeholders
A Nexalin Technology stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nexalin Technology often face trade-offs trying to please all of them. Nexalin Technology's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nexalin Technology's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John Claude | CoFounder Development | Profile | |
| Mark White | CEO, President | Profile | |
| Justin CPA | Chief Officer | Profile | |
| Marilyn Elson | Chief Officer | Profile | |
| Joel Bradus | Director Marketing | Profile | |
| Carolyn Shelton | Regulatory Quality | Profile | |
| David MD | Chief Director | Profile | |
| Michael Nketiah | Regulatory Quality | Profile |
About Nexalin Technology Management Performance
The success or failure of an entity such as Nexalin Technology often depends on how effective the management is. Nexalin Technology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nexalin management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nexalin management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company was incorporated in 2021 and is headquartered in Houston, Texas. Nexalin Technology operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.
Nexalin Technology Workforce Analysis
Traditionally, organizations such as Nexalin Technology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nexalin Technology within its industry.Nexalin Technology Manpower Efficiency
Return on Nexalin Technology Manpower
| Revenue Per Employee | 28.1K | |
| Revenue Per Executive | 21.1K | |
| Net Loss Per Employee | 1.3M | |
| Net Loss Per Executive | 950.9K | |
| Working Capital Per Employee | 569.1K | |
| Working Capital Per Executive | 426.8K |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.